These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1536983)

  • 1. Changes in bone mineralization, architecture and mechanical properties due to long-term (1 year) administration of pamidronate (APD) to adult dogs.
    Grynpas MD; Acito A; Dimitriu M; Mertz BP; Very JM
    Osteoporos Int; 1992 Mar; 2(2):74-81. PubMed ID: 1536983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from pamidronate (APD): a two-year study in the dog.
    Grynpas MD; Kasra M; Dumitriu M; Nespeca R; Very JM; Mertz BP
    Calcif Tissue Int; 1994 Oct; 55(4):288-94. PubMed ID: 7820780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs.
    Burr DB; Miller L; Grynpas M; Li J; Boyde A; Mashiba T; Hirano T; Johnston CC
    Bone; 2003 Dec; 33(6):960-9. PubMed ID: 14678856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term and high-dose bisphosphonate administration causes no bone over-mineralization].
    Liu C; Cao YP; Yang X; Mashiba T; Mori S
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2968-71. PubMed ID: 20137705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pamidronate content and turnover in sternum, vertebral body, and iliac bones of dogs.
    King LE; Grynpas MD; Tomlinson G; Vieth R
    Bone; 1997 May; 20(5):405-11. PubMed ID: 9145237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraphysiologic levels of testosterone affect cancellous and cortical bone in the young female cynomolgus monkey.
    Lundon K; Dumitriu M; Grynpas MD
    Calcif Tissue Int; 1997 Jan; 60(1):54-62. PubMed ID: 9030481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pamidronate in a new model of immobilization in the dog.
    Grynpas MD; Kasra M; Renlund R; Pritzker KP
    Bone; 1995 Oct; 17(4 Suppl):225S-232S. PubMed ID: 8579921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pamidronate on the mechanical properties of canine bone.
    Grynpas MD; Acito A; Kasra M
    Ann Oncol; 1994; 5 Suppl 7():S49-51. PubMed ID: 7873462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of high-dose zoledronic acid treatment on bone mineralization density distribution after orthotopic liver transplantation.
    Misof BM; Bodingbauer M; Roschger P; Wekerle T; Pakrah B; Haas M; Kainz A; Oberbauer R; Mühlbacher F; Klaushofer K
    Calcif Tissue Int; 2008 Sep; 83(3):167-75. PubMed ID: 18712431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin alters bone quality in beagle dogs.
    Pienkowski D; Doers TM; Monier-Faugere MC; Geng Z; Camacho NP; Boskey AL; Malluche HH
    J Bone Miner Res; 1997 Nov; 12(11):1936-43. PubMed ID: 9383698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.
    Bourrin S; Ammann P; Bonjour JP; Rizzoli R
    Bone; 2002 Jan; 30(1):195-200. PubMed ID: 11792585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low doses of strontium on bone quality and quantity in rats.
    Grynpas MD; Marie PJ
    Bone; 1990; 11(5):313-9. PubMed ID: 2252809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term effect of ovariectomy on the quality and quantity of cancellous bone in young macaques.
    Lundon K; Dumitriu M; Grynpas M
    Bone Miner; 1994 Feb; 24(2):135-49. PubMed ID: 8199533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats.
    Reitsma PH; Bijvoet OL; Verlinden-Ooms H; van der Wee-Pals LJ
    Calcif Tissue Int; 1980; 32(2):145-57. PubMed ID: 6773632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
    Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
    Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength.
    Yao W; Cheng Z; Koester KJ; Ager JW; Balooch M; Pham A; Chefo S; Busse C; Ritchie RO; Lane NE
    Bone; 2007 Nov; 41(5):804-12. PubMed ID: 17825637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
    Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
    Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
    Reitsma PH; Bijvoet OL; Potokar M; van der Wee-Pals LJ; van Wijk-van Lennep MM
    Calcif Tissue Int; 1983 May; 35(3):357-61. PubMed ID: 6871766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.